Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Papillary Renal Cell Carcinoma”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Testing effectiveness (Phase 2)Study completedNCT01524926
What this trial is testing

CREATE: Cross-tumoral Phase 2 With Crizotinib

Who this might be right for
Locally Advanced and/or Metastatic Anaplastic Large Cell LymphomaLocally Advanced and/or Metastatic Inflammatory Myofibroblastic TumorLocally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1+3 more
European Organisation for Research and Treatment of Cancer - EORTC 582
Testing effectiveness (Phase 2)Study completedNCT02761057
What this trial is testing

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Who this might be right for
Locally Advanced Papillary Renal Cell CarcinomaMetastatic Papillary Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+4 more
National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Large-scale testing (Phase 3)Active Not RecruitingNCT03091192
What this trial is testing

Savolitinib vs. Sunitinib in MET-driven PRCC.

Who this might be right for
CarcinomaCarcinoma, Renal CellKidney Neoplasms+5 more
AstraZeneca 60
Testing effectiveness (Phase 2)Looking for participantsNCT05096390
What this trial is testing

Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Who this might be right for
Papillary Renal Cell Carcinoma Type 2
Centre Leon Berard 72
Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Testing effectiveness (Phase 2)Ended earlyNCT00098618
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Not applicableLooking for participantsNCT07024680
What this trial is testing

Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT00060307
What this trial is testing

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Study completedNCT01688973
What this trial is testing

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT02489695
What this trial is testing

Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma

Who this might be right for
Papillary Renal Cell Carcinoma
Centre Leon Berard 44
Testing effectiveness (Phase 2)Study completedNCT03685448
What this trial is testing

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35